These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 2502128

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of calcium dobesilate on the inhibition of collagen fibrillogenesis by glucose in vitro.
    Schmut O.
    Arzneimittelforschung; 1989 Dec; 39(12):1555-7. PubMed ID: 2624604
    [Abstract] [Full Text] [Related]

  • 3. Calcium dobesilate and transmembrane potential in canine cardiac cells. A preliminary study.
    Nikitopoulou-Maratou G, Lymperi M, Poyatzi A, Molyvdas PA.
    Arzneimittelforschung; 1986 Sep; 36(9):1345-7. PubMed ID: 3790184
    [Abstract] [Full Text] [Related]

  • 4. Erythrocytic sorbitol contents in diabetic patients correlate with blood aldose reductase protein contents and plasma glucose levels, and are normalized by the potent aldose reductase inhibitor fidarestat (SNK-860).
    Asano T, Saito Y, Kawakami M, Yamada N, Sekino H, Hasegawa S, Fidarestat Clinical Pharmacology Study Group.
    J Diabetes Complications; 2004 Sep; 18(6):336-42. PubMed ID: 15531183
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of calcium dobesilate on blood viscosity in diabetic microangiopathy. A review.
    Barras JP, Michal M.
    Vasa; 1986 Sep; 15(3):200-5. PubMed ID: 3532608
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of aldose reductase inhibitor (ONO-2235) on human erythrocyte sorbitol concentrations in 75 g oral glucose tolerance tests.
    Kamon N, Mabuchi H, Takeda R, Terashima H.
    Horm Metab Res; 1991 May; 23(5):226-9. PubMed ID: 1908433
    [Abstract] [Full Text] [Related]

  • 9. Assessment of the anti-inflammatory action of calcium dobesilate. Effect on macrophages attaching to subcutaneously implanted coverslips in guinea pigs.
    Piller NB.
    Arzneimittelforschung; 1990 Jun; 40(6):698-700. PubMed ID: 2397006
    [Abstract] [Full Text] [Related]

  • 10. [Reduction of erythrocyte sorbitol by ascorbic acid in patients with diabetes mellitus].
    Wang H, Zhang ZB, Wen RR.
    Zhonghua Yi Xue Za Zhi; 1994 Sep; 74(9):548-51, 583. PubMed ID: 7842354
    [Abstract] [Full Text] [Related]

  • 11. [Improvement of reduced erythrocyte flexibility through calcium dobesilate. Results of a pilot study].
    Ernst E, Marshall M.
    MMW Munch Med Wochenschr; 1984 Feb 03; 126(5):125-6. PubMed ID: 6423981
    [No Abstract] [Full Text] [Related]

  • 12. [Platelet aggregation inhibition with calcium dobesilate].
    Heidrich H, Gerke E, Nekarda H.
    Arzneimittelforschung; 1983 Feb 03; 33(4):580-2. PubMed ID: 6683538
    [Abstract] [Full Text] [Related]

  • 13. Effects of a new aldose reductase inhibitor on various tissues in vitro.
    Terashima H, Hama K, Yamamoto R, Tsuboshima M, Kikkawa R, Hatanaka I, Shigeta Y.
    J Pharmacol Exp Ther; 1984 Apr 03; 229(1):226-30. PubMed ID: 6423811
    [Abstract] [Full Text] [Related]

  • 14. Calcium dobesilate (Doxium) as a prostaglandin synthetase inhibitor in pregnant human myometrium in vitro.
    Falkay G, Kovács L.
    Experientia; 1984 Feb 15; 40(2):190-1. PubMed ID: 6421615
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [The acute hemorheologic effect of calcium dobesilate].
    Költringer P, Eber O, Klima G, Langsteger W, Wakonig P, Lind P, Rothlauer W.
    Acta Med Austriaca; 1988 Feb 15; 15(3):78-80. PubMed ID: 3223220
    [Abstract] [Full Text] [Related]

  • 18. Reduction of retinal albumin leakage by the antioxidant calcium dobesilate in streptozotocin-diabetic rats.
    Rota R, Chiavaroli C, Garay RP, Hannaert P.
    Eur J Pharmacol; 2004 Jul 14; 495(2-3):217-24. PubMed ID: 15249173
    [Abstract] [Full Text] [Related]

  • 19. Effect of sorbitol dehydrogenase inhibition on sugar cataract formation in galactose-fed and diabetic rats.
    Kador PF, Inoue J, Secchi EF, Lizak MJ, Rodriguez L, Mori K, Greentree W, Blessing K, Lackner PA, Sato S.
    Exp Eye Res; 1998 Aug 14; 67(2):203-8. PubMed ID: 9733586
    [Abstract] [Full Text] [Related]

  • 20. The effect of aldose reductase inhibition on erythrocyte polyols and galactitol accumulation in diabetic patients.
    Airey CM, Price DE, Kemp JV, Perkins CM, Wales JK.
    Diabet Med; 1989 Dec 14; 6(9):804-8. PubMed ID: 2533041
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.